Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries

Serena Marcozzi, Valerio Rossi, Giulia Salvatore, Francesca Di Rella, Massimo De Felici, Francesca Gioia Klinger

Research output: Contribution to journalArticle

Abstract

In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on somatic cells from prepuberal mouse ovaries. All cell types (pre-and granulosa cells, pre-thecal and OSE cells) underwent apoptosis following Epirubicin (0.5μM) exposure for 24hrs (about 60%) and 48hrs (>;80%). Cisplatin (10μM) and the Cyclophosphamide active metabolite, Phosphoramide Mustard (10μM), didn't cause apoptosis in 90% of pre-thecal and pre-granulosa cells up to 72hrs of exposure, although they suffered extensive DNA damage and cell cycle arrest, and acquired stress induced premature senescence (SIPS) features. Cultured granulosa cells didn't show evident DNA damage and remained viable without acquiring SIPS features; OSE cells were resistant to apoptosis and SIPS but not to DNA damage. These latter, like pre-thecal and pre-granulosa cells, were able of efficient DNA repair involving MLH1-dependent MMR pathways. SIPS features were also observed in ovary after in vivo treatment with Cisplatin. LH (200mIU/mL) didn't significantly influence apoptosis, SIPS and DNA damage but favoured DNA repair. These results show that somatic cells of prepuberal ovary response to drugs in different ways, either undergoing apoptosis or SIPS, either showing resistance to Cisplatin and Phosphoramide Mustard. Moreover, a new role of LH in promoting DNA repair was shown.

Original languageEnglish
Pages (from-to)10532-10556
Number of pages25
JournalAging
Volume11
Issue number22
DOIs
Publication statusPublished - Jan 1 2019

Keywords

  • Chemotherapy
  • Cisplatin
  • Cyclophosphamide
  • Epirubicin
  • Ovary

ASJC Scopus subject areas

  • Ageing
  • Cell Biology

Cite this

Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries. / Marcozzi, Serena; Rossi, Valerio; Salvatore, Giulia; Di Rella, Francesca; De Felici, Massimo; Klinger, Francesca Gioia.

In: Aging, Vol. 11, No. 22, 01.01.2019, p. 10532-10556.

Research output: Contribution to journalArticle

Marcozzi, S, Rossi, V, Salvatore, G, Di Rella, F, De Felici, M & Klinger, FG 2019, 'Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries', Aging, vol. 11, no. 22, pp. 10532-10556. https://doi.org/10.18632/aging.102476
Marcozzi, Serena ; Rossi, Valerio ; Salvatore, Giulia ; Di Rella, Francesca ; De Felici, Massimo ; Klinger, Francesca Gioia. / Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries. In: Aging. 2019 ; Vol. 11, No. 22. pp. 10532-10556.
@article{af54f5f60cbe4e1ab8492a0e08e21f3e,
title = "Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries",
abstract = "In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on somatic cells from prepuberal mouse ovaries. All cell types (pre-and granulosa cells, pre-thecal and OSE cells) underwent apoptosis following Epirubicin (0.5μM) exposure for 24hrs (about 60{\%}) and 48hrs (>;80{\%}). Cisplatin (10μM) and the Cyclophosphamide active metabolite, Phosphoramide Mustard (10μM), didn't cause apoptosis in 90{\%} of pre-thecal and pre-granulosa cells up to 72hrs of exposure, although they suffered extensive DNA damage and cell cycle arrest, and acquired stress induced premature senescence (SIPS) features. Cultured granulosa cells didn't show evident DNA damage and remained viable without acquiring SIPS features; OSE cells were resistant to apoptosis and SIPS but not to DNA damage. These latter, like pre-thecal and pre-granulosa cells, were able of efficient DNA repair involving MLH1-dependent MMR pathways. SIPS features were also observed in ovary after in vivo treatment with Cisplatin. LH (200mIU/mL) didn't significantly influence apoptosis, SIPS and DNA damage but favoured DNA repair. These results show that somatic cells of prepuberal ovary response to drugs in different ways, either undergoing apoptosis or SIPS, either showing resistance to Cisplatin and Phosphoramide Mustard. Moreover, a new role of LH in promoting DNA repair was shown.",
keywords = "Chemotherapy, Cisplatin, Cyclophosphamide, Epirubicin, Ovary",
author = "Serena Marcozzi and Valerio Rossi and Giulia Salvatore and {Di Rella}, Francesca and {De Felici}, Massimo and Klinger, {Francesca Gioia}",
year = "2019",
month = "1",
day = "1",
doi = "10.18632/aging.102476",
language = "English",
volume = "11",
pages = "10532--10556",
journal = "Aging",
issn = "1945-4589",
publisher = "US Administration on Aging",
number = "22",

}

TY - JOUR

T1 - Distinct effects of epirubicin, cisplatin and cyclophosphamide on ovarian somatic cells of prepuberal ovaries

AU - Marcozzi, Serena

AU - Rossi, Valerio

AU - Salvatore, Giulia

AU - Di Rella, Francesca

AU - De Felici, Massimo

AU - Klinger, Francesca Gioia

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on somatic cells from prepuberal mouse ovaries. All cell types (pre-and granulosa cells, pre-thecal and OSE cells) underwent apoptosis following Epirubicin (0.5μM) exposure for 24hrs (about 60%) and 48hrs (>;80%). Cisplatin (10μM) and the Cyclophosphamide active metabolite, Phosphoramide Mustard (10μM), didn't cause apoptosis in 90% of pre-thecal and pre-granulosa cells up to 72hrs of exposure, although they suffered extensive DNA damage and cell cycle arrest, and acquired stress induced premature senescence (SIPS) features. Cultured granulosa cells didn't show evident DNA damage and remained viable without acquiring SIPS features; OSE cells were resistant to apoptosis and SIPS but not to DNA damage. These latter, like pre-thecal and pre-granulosa cells, were able of efficient DNA repair involving MLH1-dependent MMR pathways. SIPS features were also observed in ovary after in vivo treatment with Cisplatin. LH (200mIU/mL) didn't significantly influence apoptosis, SIPS and DNA damage but favoured DNA repair. These results show that somatic cells of prepuberal ovary response to drugs in different ways, either undergoing apoptosis or SIPS, either showing resistance to Cisplatin and Phosphoramide Mustard. Moreover, a new role of LH in promoting DNA repair was shown.

AB - In vitro culture models were used to characterize the effects of chemotherapeutic drugs and of LH on somatic cells from prepuberal mouse ovaries. All cell types (pre-and granulosa cells, pre-thecal and OSE cells) underwent apoptosis following Epirubicin (0.5μM) exposure for 24hrs (about 60%) and 48hrs (>;80%). Cisplatin (10μM) and the Cyclophosphamide active metabolite, Phosphoramide Mustard (10μM), didn't cause apoptosis in 90% of pre-thecal and pre-granulosa cells up to 72hrs of exposure, although they suffered extensive DNA damage and cell cycle arrest, and acquired stress induced premature senescence (SIPS) features. Cultured granulosa cells didn't show evident DNA damage and remained viable without acquiring SIPS features; OSE cells were resistant to apoptosis and SIPS but not to DNA damage. These latter, like pre-thecal and pre-granulosa cells, were able of efficient DNA repair involving MLH1-dependent MMR pathways. SIPS features were also observed in ovary after in vivo treatment with Cisplatin. LH (200mIU/mL) didn't significantly influence apoptosis, SIPS and DNA damage but favoured DNA repair. These results show that somatic cells of prepuberal ovary response to drugs in different ways, either undergoing apoptosis or SIPS, either showing resistance to Cisplatin and Phosphoramide Mustard. Moreover, a new role of LH in promoting DNA repair was shown.

KW - Chemotherapy

KW - Cisplatin

KW - Cyclophosphamide

KW - Epirubicin

KW - Ovary

UR - http://www.scopus.com/inward/record.url?scp=85076016139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076016139&partnerID=8YFLogxK

U2 - 10.18632/aging.102476

DO - 10.18632/aging.102476

M3 - Article

C2 - 31711044

AN - SCOPUS:85076016139

VL - 11

SP - 10532

EP - 10556

JO - Aging

JF - Aging

SN - 1945-4589

IS - 22

ER -